CCRN — Cross Country Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- $296.69m
- $187.95m
- $1.05bn
Annual cashflow statement for Cross Country Healthcare, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 132 | 188 | 72.6 | -14.6 | -94.9 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 19.7 | 34.1 | 28.7 | 30.8 | 85.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -237 | -106 | 127 | 87.6 | 30.5 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -85.6 | 134 | 248 | 120 | 48.3 |
| Capital Expenditures | -7.17 | -8.79 | -14 | -8.71 | -8.16 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -26.9 | -35.1 | 0.199 | — | 0 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Cash from Investing Activities | -34 | -43.9 | -13.8 | -8.71 | -8.16 |
| Financing Cash Flow Items | -8.58 | -17.1 | -12.9 | -9.54 | -6.17 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 119 | -87.6 | -221 | -46.8 | -13 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.564 | 2.57 | 13.5 | 64.5 | 27.1 |